• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 sp. HM71 作为人类健康潜在益生菌菌株。

Characterization of sp. HM71 as potential probiotic strain for human health.

机构信息

Department of Biochemistry, Maharshi Dayanand University, Rohtak, Haryana, India.

INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) Laboratory, Division of Immunology and Infectious Diseases, Council of Scientific & Industrial Research-Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.

出版信息

Front Cell Infect Microbiol. 2023 Jan 13;12:1082674. doi: 10.3389/fcimb.2022.1082674. eCollection 2022.

DOI:10.3389/fcimb.2022.1082674
PMID:36710963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9880229/
Abstract

sp. HM71, a human gut microbe possesses metabolic machinery to catabolize antigenic gluten, hence, holds promises as microbial therapy to treat gluten-derived celiac disease. However, its efficacy, safety, and survivability in the gastrointestinal ecosystem await functional elucidation. The current study is designed to characterize sp. HM71 for its physiological, genomic, and probiotic properties. The morphological and physiological assessment indicates it as a coccus-shaped gram-positive bacterium growing optimally at 30°C in a neutral environment (pH 7.0). sp. HM71 showed continuous growth even in stressful environments (salinity up to 3% NaCl and 6% KCl), variable temperature (25°C to 35°C) and pH (5-9), antibiotics, and gastric and intestinal conditions. The sp. HM71 genome harbors diversified genetic machinery to modulate humongous metabolic potential for the host. This was substantiated by the hemolytic and CaCo-2 cell line assay which confirms its cellular adherence and biosafety. Notably, genome analysis did not identify any pathogenic islands. Probiotic characterization indicates its potential to overcome waterborne infections and digestion-related disorders. Cumulatively, sp. HM71 can be considered a probiotic strain for improving human health because of the highlighted functions.

摘要

HM71 是人肠道微生物,具有代谢抗原性谷蛋白的机制,因此有望成为治疗源于谷蛋白的乳糜泻的微生物疗法。然而,其在胃肠道生态系统中的疗效、安全性和生存能力仍有待功能阐明。本研究旨在对 HM71 进行生理、基因组和益生菌特性的表征。形态和生理评估表明,它是一种球菌状革兰氏阳性细菌,在中性环境(pH7.0)中最适生长温度为 30°C。HM71 即使在压力环境(盐度高达 3%NaCl 和 6%KCl、温度(25°C 至 35°C)和 pH(5-9)、抗生素以及胃和肠道条件下)下也能持续生长。HM71 基因组具有多样化的遗传机制,可调节宿主巨大的代谢潜力。这一点通过溶血和 CaCo-2 细胞系测定得到了证实,该测定证实了其细胞黏附和生物安全性。值得注意的是,基因组分析未发现任何致病岛。益生菌特性表明,它有潜力克服水传播感染和与消化有关的疾病。总之,由于强调了这些功能,HM71 可以被认为是一种改善人类健康的益生菌菌株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/9610c1169373/fcimb-12-1082674-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/df2ed14be004/fcimb-12-1082674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/da6d86773f93/fcimb-12-1082674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/6fb7abd6ff3b/fcimb-12-1082674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/a94218f1bd09/fcimb-12-1082674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/5c6b00a5a83d/fcimb-12-1082674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/ae681e27a03c/fcimb-12-1082674-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/9610c1169373/fcimb-12-1082674-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/df2ed14be004/fcimb-12-1082674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/da6d86773f93/fcimb-12-1082674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/6fb7abd6ff3b/fcimb-12-1082674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/a94218f1bd09/fcimb-12-1082674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/5c6b00a5a83d/fcimb-12-1082674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/ae681e27a03c/fcimb-12-1082674-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9417/9880229/9610c1169373/fcimb-12-1082674-g007.jpg

相似文献

1
Characterization of sp. HM71 as potential probiotic strain for human health.鉴定 sp. HM71 作为人类健康潜在益生菌菌株。
Front Cell Infect Microbiol. 2023 Jan 13;12:1082674. doi: 10.3389/fcimb.2022.1082674. eCollection 2022.
2
S9A Serine Protease Engender Antigenic Gluten Catabolic Competence to the Human Gut Microbe.S9A丝氨酸蛋白酶赋予人类肠道微生物分解抗原性谷蛋白的能力。
Indian J Microbiol. 2018 Sep;58(3):294-300. doi: 10.1007/s12088-018-0732-2. Epub 2018 Apr 27.
3
Cellulomonas macrotermitis sp. nov., a chitinolytic and cellulolytic bacterium isolated from the hindgut of a fungus-growing termite.大白蚁纤维单胞菌新种,一种从培菌白蚁后肠分离出的几丁质分解和纤维素分解细菌。
Antonie Van Leeuwenhoek. 2018 Mar;111(3):471-478. doi: 10.1007/s10482-017-0968-6. Epub 2017 Oct 31.
4
Isolation and Characterization of Human Intestinal Bacteria NB2 for Probiotic Potential.具有益生菌潜力的人肠道细菌NB2的分离与鉴定
Front Microbiol. 2022 Jul 13;13:932795. doi: 10.3389/fmicb.2022.932795. eCollection 2022.
5
Cellulomonas taurus sp. nov., a novel bacteria with multiple hydrolase activity isolated from livestock, and potential application in wastewater treatment.牛型纤毛菌,一种新型细菌,具有多种水解酶活性,从家畜中分离出来,具有潜在的在废水处理中的应用。
Antonie Van Leeuwenhoek. 2021 May;114(5):527-538. doi: 10.1007/s10482-021-01538-2. Epub 2021 Mar 12.
6
Characterization and flocculation properties of biopolymeric flocculant (glycosaminoglycan) produced by Cellulomonas sp. Okoh.由 Cellulomonas sp. Okoh 产生的生物聚合絮凝剂(糖胺聚糖)的特性和絮凝性能。
J Appl Microbiol. 2013 May;114(5):1325-37. doi: 10.1111/jam.12095. Epub 2013 Mar 19.
7
Cellulomonas aerilata sp. nov., isolated from an air sample.新种气生纤维单胞菌,从空气样本中分离得到。
Int J Syst Evol Microbiol. 2008 Dec;58(Pt 12):2925-9. doi: 10.1099/ijs.0.2008/002253-0.
8
Phenotypic and genetic characterization of clinical isolates of CDC coryneform group A-3: proposal of a new species of Cellulomonas, Cellulomonas denverensis sp. nov.CDC棒状杆菌A-3群临床分离株的表型和遗传特征:丹佛纤维单胞菌新种的提议,丹佛纤维单胞菌(Cellulomonas denverensis sp. nov.)
J Clin Microbiol. 2005 Apr;43(4):1732-7. doi: 10.1128/JCM.43.4.1732-1737.2005.
9
Cellulomonas phragmiteti sp. nov., a cellulolytic bacterium isolated from reed (Phragmites australis) periphyton in a shallow soda pond.芦苇纤维单胞菌新种,一种从浅苏打池塘芦苇(芦苇)周丛生物中分离出的纤维素分解细菌。
Int J Syst Evol Microbiol. 2011 Jul;61(Pt 7):1662-1666. doi: 10.1099/ijs.0.022608-0. Epub 2010 Aug 20.
10
Cellulomonas pakistanensis sp. nov., a moderately halotolerant Actinobacteria.巴基斯坦纤维单胞菌,一种中等嗜盐放线菌。
Int J Syst Evol Microbiol. 2014 Jul;64(Pt 7):2305-2311. doi: 10.1099/ijs.0.059063-0. Epub 2014 Apr 14.

引用本文的文献

1
Therapeutic targeting of the host-microbiota-immune axis: implications for precision health.宿主-微生物群-免疫轴的治疗靶向:对精准健康的意义。
Front Immunol. 2025 Apr 29;16:1570233. doi: 10.3389/fimmu.2025.1570233. eCollection 2025.
2
Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine.推进微生物群疗法:合成生物学在构建用于精准医学的微生物群落中的作用。
Front Bioeng Biotechnol. 2024 Dec 4;12:1511149. doi: 10.3389/fbioe.2024.1511149. eCollection 2024.
3
Unveiling wheat growth promotion potential of phosphate solubilizing PS1 and PS2 through genomic, physiological, and metagenomic characterizations.

本文引用的文献

1
Isolation and Characterization of Human Intestinal Bacteria NB2 for Probiotic Potential.具有益生菌潜力的人肠道细菌NB2的分离与鉴定
Front Microbiol. 2022 Jul 13;13:932795. doi: 10.3389/fmicb.2022.932795. eCollection 2022.
2
Recent Strategies for the Immobilization of Therapeutic Enzymes.治疗性酶固定化的最新策略。
Polymers (Basel). 2022 Mar 30;14(7):1409. doi: 10.3390/polym14071409.
3
Microbiome therapeutics: exploring the present scenario and challenges.微生物组疗法:探索当前现状与挑战
通过基因组、生理学和宏基因组学表征揭示解磷菌PS1和PS2促进小麦生长的潜力。
Front Microbiol. 2024 Sep 9;15:1467082. doi: 10.3389/fmicb.2024.1467082. eCollection 2024.
4
Biofertilizer and biocontrol properties of BCM emphasize its potential application for sustainable agriculture.生物炭的生物肥料和生物防治特性突出了其在可持续农业中的潜在应用价值。
Front Plant Sci. 2024 Mar 4;15:1364807. doi: 10.3389/fpls.2024.1364807. eCollection 2024.
Gastroenterol Rep (Oxf). 2021 Nov 15;10:goab046. doi: 10.1093/gastro/goab046. eCollection 2022.
4
Safety assessment and probiotic characteristics of Enterococcus lactis JDM1.嗜酸乳球菌 JDM1 的安全性评估及益生菌特性。
Microb Pathog. 2022 Feb;163:105380. doi: 10.1016/j.micpath.2021.105380. Epub 2022 Jan 1.
5
Probiotic Characterization of Indigenous Kocuria flava Y4 Strain Isolated from Dioscorea villosa Leaves.从黄独叶片中分离的土著节杆菌 Y4 菌株的益生菌特性。
Probiotics Antimicrob Proteins. 2023 Jun;15(3):614-629. doi: 10.1007/s12602-021-09877-2. Epub 2021 Nov 25.
6
Tryptophan Metabolism and Gut-Brain Homeostasis.色氨酸代谢与肠道-脑稳态
Int J Mol Sci. 2021 Mar 15;22(6):2973. doi: 10.3390/ijms22062973.
7
Mapping of the benzoate metabolism by human gut microbiome indicates food-derived metagenome evolution.人类肠道微生物组对苯甲酸代谢的映射表明了食物衍生宏基因组的进化。
Sci Rep. 2021 Mar 10;11(1):5561. doi: 10.1038/s41598-021-84964-6.
8
Catabolic Machinery of the Human Gut Microbes Bestow Resilience Against Vanillin Antimicrobial Nature.人类肠道微生物的分解代谢机制赋予其抵御香草醛抗菌特性的能力。
Front Microbiol. 2020 Oct 16;11:588545. doi: 10.3389/fmicb.2020.588545. eCollection 2020.
9
Gut Microbiome and Depression: How Microbes Affect the Way We Think.肠道微生物群与抑郁症:微生物如何影响我们的思维方式。
Cureus. 2020 Aug 23;12(8):e9966. doi: 10.7759/cureus.9966.
10
Bacterial Natural Compounds with Anti-Inflammatory and Immunomodulatory Properties (Mini Review).具有抗炎和免疫调节特性的细菌天然化合物(综述)。
Drug Des Devel Ther. 2020 Sep 18;14:3787-3801. doi: 10.2147/DDDT.S261283. eCollection 2020.